Ghic Advisors, LLC
Emerging managerSEC exempt reporting adviser (venture capital exemption).
- Website
- https://ghicfunds.org/
- HQ
- NY
Ghic Advisors, LLC is associated with Global Health Investment Corporation, which aims to catalyze the development of technologies that improve human health worldwide. The firm has invested in Access Bio, Antheia, Prenosis, and Terrestrial Bio, and it launched the Global Health Security Fund, L.P.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Biotech, Medical devices | Not enough dated deals |
| Regions | Global | Not enough dated deals |
Says: what the firm's funds state. Does: from 3 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Global Health Security Fund, L.P. | 2024 | $272.59M (Form D) | Open, writing first checks |
03 · People across funds
- Charlie Petty, Managing Director of the General Partner of the Issuer
Global Health Security Fund, L.P. (Named on Form D)
- Labeeb Abboud, Chief Executive Officer of the General Partner of the Issuer
Global Health Security Fund, L.P. (Named on Form D)
- Vidya Vasu-Devan, Chief Investment Officer of the General Partner of the Issuer
Global Health Security Fund, L.P. (Named on Form D)
04 · Recent deals
- Mar 26, 2026Terrestrial Bio, Inc.GrowthFirmsource
- Feb 3, 2026PrenosisSeries AFirmsource
- Jan 28, 2026AntheiaStage unknownFirmsource
- Oct 10, 2024CytovaleStage unknownGlobal Health Security Fund, L.P.source
05 · Latest from the firm
- New fundGHIC Announces the Launch of the Global Health Security Fund with $353M in CommitmentsMay 21, 2026
- InvestmentTerrestrial Bio (formerly Vaxess Technologies) Raises $50M Series C to Advance Microarray Patch PlatformMar 26, 2026
- InvestmentGHIC Invests in Prenosis as Company Secures $20M Series A and $20M BARDA Contract to Advance Precision Diagnostics and TherapeuticsFeb 3, 2026
- InvestmentGHIC Portfolio Company Antheia Raises Additional $24M, Bringing Series C to $80M FundedJan 28, 2026
06 · Sources
- https://ghicfunds.org/
- https://ghicfunds.org/contact/
- https://ghicfunds.org/2026/02/03/ghic-invests-in-prenosis-as-company-secures-20m-series-a-and-20m-barda-contract-to-advance-precision-diagnostics-and-therapeutics
- https://ghicfunds.org/2026/05/21/ghic-announces-the-launch-of-the-global-health-security-fund-with-353m-in-commitments
- https://ghicfunds.org/portfolio/
- https://ghicfunds.org/2026/03/26/terrestrial-bio-formerly-vaxess-technologies-raises-50m-series-c-to-advance-microarray-patch-platform
- https://ghicfunds.org/2026/01/28/ghic-portfolio-company-antheia-raises-additional-24-million-bringing-series-c-to-80-million-funded
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026